The SCORPIO-PEP trial found the drug ensitrelvir, already approved in Japan to treat people with mild to moderate COVID-19, may protect against the illness. In the study, uninfected people who began ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

A popular weight loss drug reduced the risk of COVID-19 deaths, according to a new study. The research, published Friday in the Journal of the American College of Cardiology, found during a ...

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Interest in the anti-parasitic drug ivermectin skyrocketed during the covid-19 pandemic, but evidence for many of its ...

Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...

Only 8% of the patients between the ages of 18-65 who were hospitalized for any illness during the CDC study period had been immunized with the 2024-2025 vaccine.

Recipients of the Pfizer mRNA vaccine experienced more all-cause deaths within the first 100 days post-vaccination than those who received the Moderna shot, a new study of 1.47 million people found..

On Monday, Moderna published the results of a late-stage study of mRNA-1010, its seasonal flu vaccine. In a phase 3 clinical ...

The drug won a Nobel Prize in 2015 for its role in treating parasitic diseases, however, Banta also noted that the drug has been explored to treat other illnesses such as COVID-19.

June 13 (UPI) --A new study from UCLA Health suggests COVID-19 vaccines may protect patients from severe kidney damage. The study found hospitalized COVID-19 patients were less likely to have ...

Practices can delabel other suspected drug allergies while assessing patients for allergies to COVID-19 vaccines, according to a study published in Vaccine. This program can improve health-related ...